📌 Key Takeaways
- Topic: Spherical Silica for Semiconductor Packaging: Key Specs, Purity and Selection Guide
- Keywords: is silicon dioxide acidic
- Published: 2026-11-20 13:29:48
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status
- Silica Antiblocking Agent: How It Works, Particle Size Selection and Uses
- Quartz Sand Price: 2026 Price Ranges by Purity and Mesh Size
- Mesoporous silica nanocarriers (MSNs) have emerged as considerable candidates in the pharmaceutical industry for drug delivery systems, suitable for a wide range of drugs. Absorbing the active pharmaceutical ingredients (APIs) into the pores can be handy in several ways. The narrow pores may stabilize the APIs in an amorphous state, thereby boosting its aqueous solubility and supplying protection for the encapsulated drug against various takes into consideration the human body, such as enzymatic or chemical degradation, which boosts the bioavailability of the product. Beside the overview of their main traits, the present review focuses on the recent findings on MSNs form therapeutic and drug formulation perspective, such as functionalization possibilities, as the size and surface of the particles influence the interactions with the cell membrane; therefore, the epithelial permeability of and release rate from the carrier, and may offer even targeted delivery in an organ-, tissue- or cell-specific manner, improving the therapy, also steering clear of drug-related side impacts.
- Silica for Powder Coatings: Flow Aid, Matting and Anti-Caking Functions
- 9. Mitran R.A., Deaconu M., Matei C., Berger D. Nanocarriers for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery. Elsevier Science Ltd.; Amsterdam, The Netherlands: 2018. Mesoporous Silica as Carrier for Drug-Delivery Systems; pp. 351-374. [ Google Scholar ]
- Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained
- In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].
What Is Hollow Silica? Structure, Properties and Applications
What is silica (SiO₂)?
diatomaceous earth 25. Janjua T.I., Cao Y., Kleitz F., Linden M., Yu C., Popat A. Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers. Adv. Drug Deliv. Rev. 2023;203:115115. doi: 10.1016/j.addr.2023.115115. [ DOI ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica carrier for pesticides 6.2.1. Dermal Drug Administration
What drives silica raw material prices?
silicon dioxide covalent network Silica nanoparticles can be created and used in diverse shapes (sphere, cube, ellipsoid, rod). The shape of the particles can be characterized by the facet ratio, which is 1 for spherical particles, but can reach 4 in the case of elongated rod-shaped ones [ 1 ]. Particles with different aspect ratios may exhibit different biodistribution and elimination [ 10, 19, 25 ]. The residence time in the gastrointestinal system is influenced by the particle shape [ 1, 19 ]. Spherical nanoparticles have a shorter residence time than rod-shaped ones [ 19 ] and tend to accumulate in the liver. Simultaneously, in the case of rods, a more significant accumulation is observed in the spleen [ 10 ]. In addition, particles with a higher element ratio exert longer half-life in the bloodstream and show slower elimination [ 1, 19 ], possibly due to faster renal excretion of spherical than rod-shaped particles [ 19, 25 ]. By increasing the facet ratio, a longer degradation time can also be observed [ 25 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.